January/February's product news
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
European Commission grants marketing authorisation to aflibercept biosimilar EYLUXVI (ALT-L9)
Higher Molar Dose and Its Translation into Clinical Practice
BVI, VirtuaLens will showcase new technologies at ESCRS 2025
Upcoming company presentations from Alcon, J&J, B+L at ESCRS 2025
Ciliatech leadership comments on CE mark for novel glaucoma device
EURETINA grants Prithvi Ramtohul, MD, 2025 Ramin Tadayoni Award